Joint hypermobility syndrome: a risk factor for fixed dystonia?

Mov Disord. 2012 Jul;27(8):1070. doi: 10.1002/mds.25004. Epub 2012 Apr 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Dyskinesia Agents / therapeutic use
  • Botulinum Toxins / therapeutic use
  • Dystonia / drug therapy
  • Dystonia / etiology*
  • Ehlers-Danlos Syndrome / complications*
  • Female
  • Humans
  • Joint Instability / congenital
  • Male
  • Middle Aged
  • Risk Factors
  • Young Adult

Substances

  • Anti-Dyskinesia Agents
  • Botulinum Toxins

Supplementary concepts

  • Joint laxity, familial